Stent fracture after sirolimus-eluting stent implantation: 8-year clinical outcomes

Circulation: Cardiovascular Interventions

Volumn 8, Issue 8, 2015, Pages

  Ohya, Masanobu ^a   Kadota, Kazushige ^a   Tada, Takeshi ^a   Habara, Seiji ^a   Shimada, Takenobu ^a   Amano, Hidewo ^a   Izawa, Yu ^a   Hyodo, Yusuke ^a   Miyake, Koshi ^a   Otsuru, Suguru ^a   Hasegawa, Daiji ^a   Tanaka, Hiroyuki ^a   Maruo, Takeshi ^a   Katoh, Harumi ^a   Fuku, Yasushi ^a   Goto, Tsuyoshi ^a   Mitsudo, Kazuaki ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

angiography; drug eluting stent; myocardial infarction; percutaneous coronary intervention; stent fracture

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE; WARFARIN; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY DEVICE; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR PARAMETERS; CAUSE OF DEATH; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENERAL PATHOLOGICAL PARAMETERS; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIROLIMUS ELUTING CORONARY STENT; STENT FRACTURE; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION; TREATMENT OUTCOME; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DEVICES; DRUG ELUTING STENT; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; SIROLIMUS; TREATMENT OUTCOME;

EID: 84940640330     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.002664     Document Type: Article

References (24)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R, RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002 346 1773 1780. doi: 10.1056/NEJMoa012843
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 349 1315 1323. doi: 10.1056/NEJMoa035071
3. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Tatami R, Suwa S, Takizawa A, Takatsu Y, Takahashi M, Kato H, Takeda T, Lee JD, Nohara R, Ogawa H, Tei C, Horie M, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T., Long-Term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc Interv Ther 2011 26 234 245. doi: 10.1007/s12928-011-0065-0
4. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T, CREDO-Kyoto PCI/CABG registry cohort-2 investigators Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-Term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2. Circ Cardiovasc Interv 2014 7 168 179. doi: 10.1161/CIRCINTERVENTIONS.113.000987
5. Chung WS, Park CS, Seung KB, Kim PJ, Lee JM, Koo BK, Jang YS, Yang JY, Yoon JH, Kim DI, Yoon YW, Park JS, Cho YH, Park SJ., The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation. Int J Cardiol 2008 125 325 331. doi: 10.1016/j.ijcard.2007.02.033
6. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, Ishiki R, Inagaki H, Toyama J, Yokota M, Murohara T., Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol 2009 133 321 326. doi: 10.1016/j.ijcard.2007.12.067
7. Chakravarty T, White AJ, Buch M, Naik H, Doctor N, Schapira J, Kar S, Forrester JS, Weiss RE, Makkar R., Meta-Analysis of incidence, clinical characteristics and implications of stent fracture. Am J Cardiol 2010 106 1075 1080. doi: 10.1016/j.amjcard.2010.06.010
8. Mamas MA, Foin N, Abunassar C, Khan MA, Di Mario C, Fraser DG., Stent fracture: Insights on mechanisms, treatments, and outcomes from the food and drug administration manufacturer and user facility device experience database. Catheter Cardiovasc Interv 2014 83 E251 E259. doi: 10.1002/ccd.25423
9. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, Takarada S, Kitabata H, Tanimoto T, Mizukoshi M, Imanishi T, Akasaka T., Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation. Circ J 2009 73 2036 2041
10. Kuramitsu S, Iwabuchi M, Haraguchi T, Domei T, Nagae A, Hyodo M, Yamaji K, Soga Y, Arita T, Shirai S, Kondo K, Ando K, Sakai K, Goya M, Takabatake Y, Sonoda S, Yokoi H, Toyota F, Nosaka H, Nobuyoshi M., Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation. Circ Cardiovasc Interv 2012 5 663 671. doi: 10.1161/CIRCINTERVENTIONS.112.969238
11. Kuramitsu S, Iwabuchi M, Yokoi H, Domei T, Sonoda S, Hiromasa T, Morinaga T, Kobayashi Y, Ohe K, Goya K, Yamaji K, Hyodo M, Soga Y, Kondo K, Shirai S, Ando K, Sakai K, Nobuyoshi M., Incidence and clinical impact of stent fracture after the Nobori biolimus-eluting stent implantation. J Am Heart Assoc 2014 3 e000703. doi: 10.1161/JAHA.113.000703
12. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB., A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol 2009 103 923 929. doi: 10.1016/j.amjcard.2008.12.022
13. Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, Hosogi S, Hirono A, Tanaka H, Tada T, Morimoto T, Shiomi H, Kozuma K, Inoue K, Suzuki N, Kimura T, Mitsudo K., Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation 2011 123 2382 2391. doi: 10.1161/CIRCULATIONAHA.110.003459
14. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007 115 2344 2351. doi: 10.1161/CIRCULATIONAHA.106.685313
15. Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Berger PB, Iakovou I, Dangas G, Waksman R, Antoniucci D, Sartori S, Krucoff MW, Hermiller JB, Shawl F, Gibson CM, Chieffo A, Alu M, Moliterno DJ, Colombo A, Pocock S., Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 2013 382 1714 1722. doi: 10.1016/S0140-6736(13)61720-1
16. Umeda H, Kawai T, Misumida N, Ota T, Hayashi K, Iwase M, Izawa H, Sugino S, Shimizu T, Takeichi Y, Ishiki R, Inagaki H, Ozaki Y, Murohara T., Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes. Circ Cardiovasc Interv 2011 4 349 354. doi: 10.1161/CIRCINTERVENTIONS.110.958306
17. Hara H, Aoki J, Tanabe K, Tanimoto S, Nakajima Y, Yahagi K, Nakashima M, Hashimoto T, Asami M, Watanabe M, Yoshida E, Nakajima H, Hara K., Incidence and predictors for late target lesion revascularization after sirolimus-eluting stent implantation. Circ J 2013 77 988 994
18. Ito T, Kimura M, Ehara M, Terashima M, Nasu K, Kinoshita Y, Habara M, Tsuchikane E, Suzuki T., Impact of sirolimus-eluting stent fractures without early cardiac events on long-Term clinical outcomes: a multislice computed tomography study. Eur Radiol 2014 24 1006 1012. doi: 10.1007/s00330-014-3118-9
19. Lee SW, Tam FC, Chan KK., Very late stent thrombosis due to DES fracture: description of a case and review of potential causes. Catheter Cardiovasc Interv 2011 78 1101 1105. doi: 10.1002/ccd.23101
20. Ito T, Terashima M, Kaneda H, Nasu K, Kinoshita Y, Habara M, Tsuchikane E, Suzuki T., Very late sirolimus-eluting stent thrombosis due to stent fracture and late-Acquired incomplete stent apposition detected on multislice computed tomography. Circ J 2011 75 2716 2717
21. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD., Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004 109 701 705. doi: 10.1161/01.CIR.0000116202.41966.D4
22. Nakazawa G, Vorpahl M, Finn AV, Narula J, Virmani R., One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging 2009 2 625 628. doi: 10.1016/j.jcmg.2009.01.011
23. Yamaji K, Kubo S, Inoue K, Kadota K, Kuramitsu S, Shirai S, Ando K, Nobuyoshi M, Mitsudo K, Kimura T., Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis. PLoS One 2014 9 e113870. doi: 10.1371/journal.pone.0113870
24. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A., 2014 ESC/EACTS guidelines on myocardial revascularization: The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014 35 2541 2619